PHARMIA’s $LEAS goal is to become a leading generics and super-generics company within 5 years. In executing its Plan, PHARMIA will take a three stage approach to the achievement of its goals.
Stage 1
In the initial stage, PHARMIA will launch the company by acquiring MAs in Europe and ANDAs in the United States for generic products that are essential medicines in...
$LEAS has been on a tear recently and for good reason. $LEAS has risen 3,000% and continues to rise following the reinstatement of the company, the new CEO and a slew of filings. The company has also stated that it has found a Reverse Merger candidate and the website of that company will be released soon once everything is in order. In addition to filings bringing...